Cargando…

Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization

This is the first report of successful use of avatrombopag for a patient with chronic liver disease undergoing a neurosurgical procedure.

Detalles Bibliográficos
Autores principales: Lim, Ming Y., Gilreath, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509863/
https://www.ncbi.nlm.nih.gov/pubmed/32936905
http://dx.doi.org/10.1182/bloodadvances.2020003045
_version_ 1783585681008754688
author Lim, Ming Y.
Gilreath, Jeffrey A.
author_facet Lim, Ming Y.
Gilreath, Jeffrey A.
author_sort Lim, Ming Y.
collection PubMed
description This is the first report of successful use of avatrombopag for a patient with chronic liver disease undergoing a neurosurgical procedure.
format Online
Article
Text
id pubmed-7509863
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-75098632020-09-23 Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization Lim, Ming Y. Gilreath, Jeffrey A. Blood Adv Exceptional Case Report This is the first report of successful use of avatrombopag for a patient with chronic liver disease undergoing a neurosurgical procedure. American Society of Hematology 2020-09-16 /pmc/articles/PMC7509863/ /pubmed/32936905 http://dx.doi.org/10.1182/bloodadvances.2020003045 Text en © 2020 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Exceptional Case Report
Lim, Ming Y.
Gilreath, Jeffrey A.
Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
title Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
title_full Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
title_fullStr Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
title_full_unstemmed Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
title_short Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
title_sort periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
topic Exceptional Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509863/
https://www.ncbi.nlm.nih.gov/pubmed/32936905
http://dx.doi.org/10.1182/bloodadvances.2020003045
work_keys_str_mv AT limmingy periproceduraluseofavatrombopagforneurosurgicalinterventionsastrategytoavoidplateletutilization
AT gilreathjeffreya periproceduraluseofavatrombopagforneurosurgicalinterventionsastrategytoavoidplateletutilization